Secondary Myeloid Leukemia and MDS in Patients Treated for Hodgkin Lymphoma – Experience of the German Hodgkin Lymphoma Study Group (GHSG)


https://doi.org/10.4081/hmr.v2i15.605
Vol. 2 No. 15: Secondary Leukemias and leukemogenesis Rome, 3-4 November 2006
Published: June 16, 2009
Abstract Views: 273
PDF: 408
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Authors

Depending on age and risk factors, more than 80% of patients with Hodgkin Lymphoma (HL) are currently being cured.1 Long-term survivors, however, are at risk for treatment-related complications such as infertility, cardiac or pulmonary dysfunction or thyroid-related sequelae. Increased risk of secondary cancers has been observed after chemo- and radiotherapy. The malignancies most frequently associated with chemotherapy include acute myeloid leukemia (AML) and myelodysplastic syndromes (MDS).2-5

Supporting Agencies


Engert, A. (2009). Secondary Myeloid Leukemia and MDS in Patients Treated for Hodgkin Lymphoma – Experience of the German Hodgkin Lymphoma Study Group (GHSG). Hematology Meeting Reports (formerly Haematologica Reports), 2(15). https://doi.org/10.4081/hmr.v2i15.605
Authors who publish with this journal agree to the following terms: Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).

Downloads

Citations

Crossref
Scopus
Google Scholar
Europe PMC